Effectiveness and safety of vedolizumab and infliximab in biologic-naive patients with Crohn’s disease: results from the EVOLVE studyGerassimos J. Mantzaris, Andrés Yarur, Sumit Saha et al.|European Journal of Gastroenterology & Hepatology|2023Cited by 9
P621 Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn’s disease patients: results from the EVOLVE studyBrian Bressler, Andrés Yarur, Gerassimos J. Mantzaris et al.|Journal of Crohn s and Colitis|2019Cited by 8
DOP55 A real-world comparison of the effectiveness and safety of vedolizumab and anti-TNF therapies in early treatment initiation with first-line biologic therapy in ulcerative colitis: Results from EVOLVEGerassimos J. Mantzaris, Andrés Yarur, Shu Wang et al.|Journal of Crohn s and Colitis|2020Cited by 4